Pune, India – – September 22, 2026 -- The global exosomes market is set to grow nearly tenfold over the next decade, expanding from USD 230.55 million in 2025 to USD 2,250 million by 2034, according to a new analysis from Maximize Market Research. The projected 28.8% compound annual growth rate between 2026 and 2034 places exosome technology among the fastest-expanding segments in biopharmaceutical R&D.

Washington – September 22, 2026 -- Danaher Corporation (NYSE: DHR) will hold its third-quarter 2026 earnings conference call on Wednesday, October 21, 2026, at 8:00 a.m. ET, the company confirmed.

Danaher to webcast hour-long Q3 results discussion on October 21

The call, lasting approximately one hour, will be webcast via the "Investors" section of Danaher's website under "Events & Presentations," alongside a slide presentation. Investors can dial in at 800-267-6316 within the U.S. or +1 203-518-9783 outside the U.S., using Conference ID DHRQ326.